Alzheimer's & Cognition
News from the FDA/CDC
FDA issues warnings to companies selling illegal Alzheimer’s treatments
The FDA targeted more than 58 products.
From the Journals
Novel plasma biomarkers may predict preclinical Alzheimer’s disease
The approach will need to be validated and translated “to a simpler automated platform suitable for wider utility.”
Literature Review
Neurologic Disease Eventually Affects Half of Women and One-Third of Men
Around one-half of women and one-third of men will develop dementia, stroke, or parkinsonism during their lifetime,...
Literature Review
Cognitive and Behavioral Problems Increase With ALS Disease Stage
Cognitive deficits and behavioral symptoms that are specific to amyotrophic lateral sclerosis (ALS) occur more...
Latest News
Aerobic exercise may mitigate age-related cognitive decline
Among adults with below-average fitness, aerobic exercise significantly improves executive function, a randomized trial finds.
Conference Coverage
High Systemic Inflammation at Midlife Portends Cognitive Changes in Later Life
ATLANTA—Individuals with higher levels of systemic inflammation during midlife experience...
Feature
Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab stopped
The molecule will continue to be tested in a study of familial Alzheimer’s in Colombia.
Conference Coverage
Researchers Develop Guidelines for Evaluating Cognitive and Behavioral Syndromes in Adults
CHICAGO—An Alzheimer’s Association workgroup has developed 20 recommendations for the clinical...
From the Journals
SPRINT MIND published: Extension trial to add 2 years’ follow-up
Conference Coverage
Is a Unidimensional Cognitive Screen Sufficient for Patients With MS?
BERLIN—Cognitive impairment in patients with multiple sclerosis (MS) varies in presence and...
Literature Review
Frailty may affect the expression of dementia
People with higher degrees of frailty may be more likely to have more Alzheimer’s disease pathology and clinical dementia.